期刊文献+

胰岛素泵治疗2型糖尿病临床研究 被引量:8

Clinical study on the treatment of type 2 diabetes by continuous subcutaneous infusion with insulin pump
下载PDF
导出
摘要 目的:比较不同胰岛素给药方法对2型糖尿病治疗差异。方法:86例需胰岛素治疗的2型糖尿病患者住院进行了两种胰岛素强化治疗。(1)胰岛素泵连续皮下治疗组42例(CSII组);(2)多次皮下注射胰岛素治疗组44例(MSII组)。比较胰岛素泵治疗前后血糖变化、两组血糖达标时间、血糖达标时每日胰岛素的使用总量及低血糖的发生率。结果:2组患者最终均达到了目标血糖值,平均高血糖控制天数有显著性差异,CSII组:(7.84±4.13)d,MSII组:(10.26±3.26)d(P<0.01)。胰岛素用量CSII组:(37.57±7.86)u/d,MSII组:(40.26±6.25)u/d,无显著性差异(P>0.05)。而CSII组低血糖发生率低于MSII组,CSII组:(0.13±0.03)次/(人·d),MSII组:(0.24±0.06)次/(人·d),(P<0.01)。结论:CSII组可较MSII组更快更有效控制高血糖,并减少低血糖发生。 Objective To compare the effects of two different approaches of insulin delivery on hy- perghycemia. Methods Eighty-six type 2 diabetes were studied by 2 methods of intensive insulin deliv- ery, CSII group and MSII group. The average duration of treatment, insulin dosage and the hypo- glycemia were compared in the two groups. Results Both groups had reached the target BGs. The av- erage durations of treatment were significantly different, CSII(7.84±4.13) d, MSII(10.26±3.26) d (P<0.01). The insulin dosage was not significantly different, CSII(37.57±7.86) u/d, MSII(40.26 ±6.25) u/d (P>0.05).The hypoglycemia incidence in CSII was (0.13±0.03) times/(case·d), in MSII (0.24±0.06) times/(case·d) (P <0.01). Conclusion CSII can control the hyperglycemia much faster and more effectively, and reduce the hypoglycemia risk.
出处 《实用诊断与治疗杂志》 2005年第7期474-475,477,共3页 Journal of Practical Diagnosis and Therapy
关键词 2型糖尿痛 胰岛素泵 持续皮下输注 多次皮下注射 Type 2 diabetes insulin pump CSII MSII
  • 相关文献

参考文献9

二级参考文献24

  • 1王铭维.血糖与卒中[J].国外医学(脑血管疾病分册),1995,3(4):199-201. 被引量:16
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 3周成业,黄如训,曾进胜,苏镇培,陈燕奎.葡萄糖及胰岛素对高血压大鼠脑梗塞的影响[J].中国神经精神疾病杂志,1997,23(1):4-6. 被引量:64
  • 4[1]SHAO WQ, WANG XR, DU RQ, et al. Clinical observations of four cases of diabetes treated with insulin pump[ J]. Practical Medical Journal, 2002, 18 (2) :192. Chinese
  • 5[2]Pelkonen R, Koiuisto, Mustajoki P. Comparsion of insulin regimens in the therapy of type 1 diabetes [ J ]. Acta Ehdocrinol SupplCopenh, 1985, 272:49-55.
  • 6[3]Jennings Am, Lewis KS, Mundoch S, et al. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type 2 diabetic patients poorly controlled with sulfonylureas[J ]. Diabetes Care, 1991, 14: 738.
  • 7[4]Christophcr D. Saudek, Willian C. Duckworth, Anita Giobbibe-Hurber, et al. Implantable insulin pump vs multidose insulin for non-insulin dependent diabetes mellitus [J ]. JAMA, 1996, 276: 1322-1327.
  • 8[5]Schiffens T. Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump [ J ]. Psychother Psychosom Med Psychol, 1997, 47 (7): 249-254.
  • 9[6]Boland EA, Gery M, Oseterle, A, et al. Continuous subcutaneous insulin infusion: a new way to lower risk of severe by poglycemia improve metabolic conerol, and enhance coping in adolescents with type 1 diabetes [J ]. Diabetes Care, 1999, 22 (11): 1799-1784.
  • 10[7]Herman WH,Eastman RC. The effects of treatment on the direct costs of diabetes [J ]. Diabetes Care, 1998, 21 (Suppl.3):C19-24.

共引文献138

同被引文献84

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部